Review Articles

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde

"Aldo Moro" University School of Medicine, Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari
Department of Medicine I, Medical Center - University of Freiburg, Freiburg, Faculty of Medicine, University of Freiburg
Department of Clinical Hematology, CHU of Liège, Liège, Belgium; Laboratory of Hematology, GIGA-I3, University of Liège, Liège
Division of Hematology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy; Department of Oncology and Onco-Hematology, University of Milan, Milano
The Institute of Cancer Research, Division of Molecular Pathology, London, UK; The Royal Marsden Hospital, Department of Haematology, London
Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam
Stem Cell Transplantation Unit, Plasma Cell Dyscrasias Unit, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Athens
Erasmus MC Cancer Institute and Erasmus University of Rotterdam, Rotterdam
Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino
University Hospital Heidelberg Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg
Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
Department of Hematology, Rigshospitalet, Copenhagen
Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna
Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam
Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna
National and Kapodistrian University of Athens, School of Medicine, Department of Clinical Therapeutics, Athens
University Hospital Würzburg, Internal Medicine II, Würzburg
Wilhelminen Cancer Research Institute, 1st Department of Medicine, Center for Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna
Fondazione IRCCS Policlinico S. Matteo, Pavia
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino
University Hospital of Salamanca/IBSAL/CIC-IBMCC, Salamanca
Erasmus MC Cancer Institute and Erasmus University of Rotterdam, Rotterdam
Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona
Haematologica Early view Jul 15, 2021 https://doi.org/10.3324/haematol.2021.278519